Please use this identifier to cite or link to this item: https://hdl.handle.net/2440/34054
Type: Patent
Title: Tumour Suppressor Gene
Author: Callen, D.
Whitmore, S.
Kremmidiotis, G.
Kochetkova, M.
Crawford, J.
Issue Date: 2002
Assignee: Bionomics Ltd
Contributor: Griffith Hack
Statement of
Responsibility: 
Invented by D. F. Callen, S. A. Whitmore, G. Kremmidiotis, M. Kochetkova, J. Crawford, Joanna; Assigned to Bionomics Ltd; Griffith Hack agents for inventors.
Abstract: The invention provides an isolated DNA molecule comprising the nucleotide sequence set forth in SEQ ID NO: 1 or 2, or active fragments thereof, which encode a polypeptide active in suppressing cellular functions associated with cancer. In particular, the polypeptide (MTG16) functions as a tumour suppressor gene. It also provides variants of such DNA molecules which retain their function, polypeptides encoded by the DNA molecules and antibodies thereto, as well as the use of these molecules in diagnostic, prognostic and therapeutic procedures and other uses such as screening for candidate pharmaceuticals and animal model generation.
Description: PATENT: D. F. Callen, S. A. Whitmore, G. Kremmidiotis, M. Kochetkova, J. Crawford, Joanna (Assignee: Bionomics Ltd). WO 2002/018592 A1 (PCT/AU2001/001097) filed Aug 31, 2001; published Mar 7, 2002.
Patent #: PCT/AU2001/001097
Published version: http://www.wipo.int/pctdb/en/wo.jsp?WO=2002018592
Appears in Collections:Aurora harvest 6
Paediatrics publications

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.